Uxin (UXIN) Cash & Equivalents (2016 - 2026)

Uxin (UXIN) has reported Cash & Equivalents for 11 consecutive years, with $6.9 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 51.8% year-over-year to $6.9 million; the trailing twelve-month figure through Mar 2026 stood at $6.9 million (down 51.8% YoY), and the FY2025 full-year result was $11.9 million, up 245.06% from the prior year.
• Cash & Equivalents retreated to $6.9 million in Q1 2026 per UXIN's latest filing, from $11.7 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $20.2 million in Q1 2022 and bottomed at $2.4 million in Q2 2024.
• Historically, Cash & Equivalents has averaged $8.6 million across 5 years, with a median of $8.8 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Cash & Equivalents sank 89.82% in 2022, then surged 336.41% in 2025.
• Over 5 years, Cash & Equivalents stood at $15.1 million in 2022, then plunged by 81.94% to $2.7 million in 2023, then rose by 28.29% to $3.5 million in 2024, then soared by 234.76% to $11.7 million in 2025, then sank by 41.33% to $6.9 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $6.9 million, $11.7 million, and $10.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.